These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 8784072

  • 1. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
    Chegini N, Rong H, Dou Q, Kipersztok S, Williams RS.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
    [Abstract] [Full Text] [Related]

  • 2. Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression.
    Chegini N, Ma C, Tang XM, Williams RS.
    Mol Hum Reprod; 2002 Dec; 8(12):1071-8. PubMed ID: 12468639
    [Abstract] [Full Text] [Related]

  • 3. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy.
    Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Schultz GS, Chegini N.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3222-30. PubMed ID: 8784073
    [Abstract] [Full Text] [Related]

  • 4. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.
    Lee BS, Nowak RA.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):913-20. PubMed ID: 11158066
    [Abstract] [Full Text] [Related]

  • 5. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
    Luo X, Levens E, Williams RS, Chegini N.
    Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
    [Abstract] [Full Text] [Related]

  • 6. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells.
    Ding L, Xu J, Luo X, Chegini N.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5549-57. PubMed ID: 15531510
    [Abstract] [Full Text] [Related]

  • 7. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro.
    Rossi MJ, Chegini N, Masterson BJ.
    Endocrinology; 1992 Mar; 130(3):1716-27. PubMed ID: 1311246
    [Abstract] [Full Text] [Related]

  • 8. Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells.
    Chegini N, Tang XM, Ma C.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4138-43. PubMed ID: 10566662
    [Abstract] [Full Text] [Related]

  • 9. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
    Britten JL, Malik M, Levy G, Mendoza M, Catherino WH.
    Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
    [Abstract] [Full Text] [Related]

  • 10. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
    Levens E, Luo X, Ding L, Williams RS, Chegini N.
    Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
    Luo X, Ding L, Xu J, Williams RS, Chegini N.
    Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
    [Abstract] [Full Text] [Related]

  • 13. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
    Luo X, Ding L, Chegini N.
    Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
    [Abstract] [Full Text] [Related]

  • 14. Human myometrium and leiomyomas express gonadotropin-releasing hormone 2 and gonadotropin-releasing hormone 2 receptor.
    Parker JD, Malik M, Catherino WH.
    Fertil Steril; 2007 Jul; 88(1):39-46. PubMed ID: 17296196
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma.
    Senturk LM, Sozen I, Gutierrez L, Arici A.
    Am J Obstet Gynecol; 2001 Mar; 184(4):559-66. PubMed ID: 11262453
    [Abstract] [Full Text] [Related]

  • 17. Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog.
    Xu J, Luo X, Chegini N.
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1350-61. PubMed ID: 12629129
    [Abstract] [Full Text] [Related]

  • 18. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
    De Falco M, Staibano S, D'Armiento FP, Mascolo M, Salvatore G, Busiello A, Carbone IF, Pollio F, Di Lieto A.
    J Soc Gynecol Investig; 2006 May; 13(4):297-303. PubMed ID: 16697947
    [Abstract] [Full Text] [Related]

  • 19. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
    Malik M, Britten J, Cox J, Patel A, Catherino WH.
    Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate.
    Shozu M, Sumitani H, Segawa T, Yang HJ, Murakami K, Inoue M.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5405-11. PubMed ID: 11701714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.